US Stock SONN Surges Over 270% in Pre-market Trading After Announcing Plan to Launch "HYPE Edition MicroStrategy"

BlockBeats News, July 14th, the stock price of US-listed company Sonnet BioTherapeutics Holdings, Inc. (SONN) surged 273.11% in pre-market trading, with a pre-market price of $19.29, an increase of $14.05 from the previous trading price.

BlockBeats previously reported that Sonnet, a US-listed company, will merge to form Hyperliquid Strategies and launch a treasury strategy, holding 12.6 million HYPE tokens and $300 million in cash.